Chevy Chase, MD, United States of America

Patricia L Earl

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 65(Granted Patents)

Company Filing History:

11 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

National Institute of Allergy and Infectious Diseases (niaid)

patent

4. 1 out of 192

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

5. 1 out of 8,686

US Government As Represented by the Secretary of the Army

patents

6. 1 out of 1,217

The United States of America As Represented by the Department of Health

patents

where one patent can have more than one assignee

Years Active: 2000-2019

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10421978 - Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus (2019-09-24),

2. 9879231 - Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites (2018-01-30),

3. 9708392 - Monoclonal antibodies against orthopoxviruses (2017-07-18),

4. 9133480 - Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites (2015-09-15),

5. 9133478 - Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes (2015-09-15),

6. 8999336 - Monoclonal antibodies against Orthopoxviruses (2015-04-07),

7. 8916172 - MVA expressing modified HIV envelope, gag, and pol genes (2014-12-23),

8. 8404818 - Monoclonal antibodies against orthopoxviruses (2013-03-26),

9. 7914788 - Monoclonal antibodies against orthopoxviruses (2011-03-29),

10. 7867982 - MVA expressing modified HIV envelope, gag, and pol genes (2011-01-11),

11. 7303754 - MVA expressing modified HIV envelope, gag, and pol genes (2007-12-04),

12. 6171596 - Oligomeric HIV-1 envelope glycoproteins (2001-01-09),

13. 6039957 - Oligomeric HIV-1 envelope glycoproteins (2000-03-21),

Title: The Innovative Mind of Patricia L Earl

Introduction: Patricia L Earl, a pioneering inventor based in Chevy Chase, MD, has made significant contributions to the world of technology and innovation.

Latest Patents: Patricia's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power storage and efficiency.

Career Highlights: With a career spanning over two decades, Patricia has been at the forefront of cutting-edge research and development in the renewable energy sector. Her work has led to the creation of several groundbreaking technologies that have revolutionized the way we harness and utilize solar energy.

Collaborations: Throughout her career, Patricia has collaborated with leading research institutions, universities, and tech companies to further her innovative projects. Her ability to work across disciplines and bring together diverse teams has been instrumental in the success of her inventions.

Conclusion: In conclusion, Patricia L Earl's passion for innovation and her dedication to creating a more sustainable future have solidified her reputation as a trailblazing inventor in the field of renewable energy. Her work continues to inspire and drive progress in the industry.

This text is generated by artificial intelligence and may not be accurate.